caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841255734

Richard GomendozaM.D.

EndocrinologySalina, KSI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Richard Gomendoza's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
5770
WESLEY MEDICAL CENTER LLC4183
ASCENSION VIA CHRISTI HOSPITALS WICHITA INC.3240
Eileen Wong
Sleep Medicine · Streetsboro, OH
1634
ELSON, BRUCE1318
Kristin Galan
Pathology · Wichita, KS
1234
SHOFFNER, RICHARD1121
Ahmad Izard
Diagnostic Radiology · Wichita, KS
1117
Kimberly Taylor
Diagnostic Radiology · Wichita, KS
1115
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
955
Unique beneficiaries
—
Total services
2,526
Distinct HCPCS
10
Medicare payment
$91K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 40 Endocrinology providers in KS — top quintile (cohort median 1,490).
PRESCRIBING · PART D · 2024
Total Rx claims
4,363
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
50
Brand share
43.3%
Top prescribed drugs
Levothyroxine Sodium915 claims
Levothyroxine Sodium421 claims
Methimazole321 claims
Tirzepatide162 claims
Hydrocortisone161 claims
QUALITY · MIPS · 2024
Final MIPS score
85.4
Quality
79.9
Cost
71.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.44%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
108
By payment type
Food and Beverage$2K